A detailed history of Xponance, Inc. transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Xponance, Inc. holds 36,972 shares of ROIV stock, worth $431,832. This represents 0.0% of its overall portfolio holdings.

Number of Shares
36,972
Previous 71,300 48.15%
Holding current value
$431,832
Previous $751,000 48.07%
% of portfolio
0.0%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$10.36 - $11.74 $355,638 - $403,010
-34,328 Reduced 48.15%
36,972 $390,000
Q1 2024

May 13, 2024

BUY
$9.87 - $11.8 $250,846 - $299,897
25,415 Added 55.39%
71,300 $751,000
Q4 2023

Jan 31, 2024

SELL
$8.38 - $11.58 $7,701 - $10,642
-919 Reduced 1.96%
45,885 $515,000
Q3 2023

Oct 23, 2023

BUY
$9.76 - $13.19 $129,720 - $175,308
13,291 Added 39.66%
46,804 $546,000
Q2 2023

Jul 13, 2023

BUY
$7.09 - $10.08 $237,607 - $337,811
33,513 New
33,513 $337,000

Others Institutions Holding ROIV

About Roivant Sciences Ltd.


  • Ticker ROIV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 704,382,976
  • Market Cap $8.23B
  • Description
  • Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...
More about ROIV
Track This Portfolio

Track Xponance, Inc. Portfolio

Follow Xponance, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Xponance, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Xponance, Inc. with notifications on news.